跳至主要内容
临床试验/NCT03308409
NCT03308409已完成不适用

Clinical Randomized Multicentric Trial to Evaluate the Comparative Effectiveness and Safety of Three Protocols Using Low-intensity Shock Waves for the Treatment of Erectile Dysfunction

Boston Medical Group2 个研究点 分布在 2 个国家目标入组 277 人开始时间: 2017年10月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
277
试验地点
2
主要终点
IIEF-EF score 6 months after completing the treatment

研究概览

简要总结

The patients with primary erectile dysfunction (IIEF-EF <26 points), will be randomly assigned to three shockwave treatment protocols: Protocol 1 six sessions, one per week; Protocol 2, six initial sessions, one per week, followed by monthly maintenance sessions (every 4 weeks) for five months; Protocol 3, six monthly sessions. The EHS and IIEF-EF scores will be compared as well as the possible adverse events from the therapy upon beginning and completing the treatment and at the 3-month and 6-month follow-ups. Self-esteem and quality of life will also be evaluated using the SEAR scale.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Men over 18 years of age
  • •Presence of ED for more than 3 months in over 50% of sexual intercourses.
  • •Baseline ED domain score under 26 on the IIEF-15 EF domain.
  • •Patient agrees to participate in the trial by providing signed informed consent.

排除标准

  • •EHS score of
  • •Patients with an INR over
  • •Patients with sickle-cell anemia.
  • •Patients with clinical suspicion of hypogonadism (AMS over 36).
  • •Endocrine diseases that present with ED, such as acromegaly, gigantism, Addison's disease, hyperprolactinemia, androgen deficiency.
  • •Active vesicular, prostrate or colon cancer.
  • •Radical prostatectomy or other radical pelvic surgery.
  • •History of pelvic radiation therapy.
  • •Patients with ED of psychological origin.
  • •Spinal cord injury or other neurological diseases associated with ED.
  • •Anatomical penile dysfunction, penile implant.
  • •Patients with active infections or lesions on the penis or pubic area.
  • •Patients with ED secondary to drug therapy (antiandrogen therapy, alpha blockers for BPH, use of corticosteroids, medication for Parkinson's disease, antipsychotics).
  • •Abuse of psychoactive substances.

研究组 & 干预措施

Protocol 1

Active Comparator

Low-intensity extracorporeal shock wave therapy (Li-ESWT): Six sessions, one per week, with 3000 pulses at 0.20 mj/mm2, at a frequency of 4Hz. At all of the shockwave sessions, 2000 pulses will be distributed to the body of the penis and 1000 pulses will be applied to the base.

干预措施: Low-intensity extracorporeal shock wave therapy (Li-ESWT) (Other)

Protocol 2

Experimental

Low-intensity extracorporeal shock wave therapy (Li-ESWT): Six initial sessions, one per week, with 3000 pulses at 0.20 mj/mm2, at a frequency of 4Hz for six weeks, followed by monthly maintenance sessions (every 4 weeks) for five months. At all of the shockwave sessions, 2000 pulses will be distributed to the body of the penis and 1000 pulses will be applied to the base.

干预措施: Low-intensity extracorporeal shock wave therapy (Li-ESWT) (Other)

Protocol 3

Experimental

Low-intensity extracorporeal shock wave therapy (Li-ESWT): Six monthly sessions in which 3000 pulses will be applied at 0.20 mj/mm2, at a frequency of 4Hz, with 2000 pulses distributed to the body of the penis and 1000 pulses applied to the base

干预措施: Low-intensity extracorporeal shock wave therapy (Li-ESWT) (Other)

结局指标

主要结局

IIEF-EF score 6 months after completing the treatment

时间窗: 6 month follow-ups

This is a highly sensitive and specific scale for detecting changes in erectile function in response to treatment. The degree of dysfunction is scored on a range of 0 to 30 points on the Erectile Functioning domain (questions 1, 2, 3, 4, 5, 15). The categories are: severe between 0 and 10, moderate between 11 and 16, mild-to-moderate between 17 and 21, mild between 22 and 25, and no ED between 26 and 30.

次要结局

  • Number of satisfactory relations(3-month and 6-month follow-ups)
  • Erection Hardness Score(3-month and 6-month follow-ups)
  • Clinical improvement(6-month follow-ups)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验